Discover
VANI
Vivani Medical, Inc.
1.23
2 x 0.88
2 x 1.56
bid
ask
-
0.01
0.81%
2 @ 04:00 PM
1.26 +0.03 (2.83%)
| Ytd | 0.00% | |
| 1y | -2.38% |
1.20
day range
1.25
0.92
52 week range
1.92
| Open | 1.20 | Prev Close | 1.24 | Low | 1.20 | High | 1.25 | Mkt Cap | 106.07M |
| Vol | 48.84K | Avg Vol | 222.42K | EPS | -0.40 | P/E | N/A | Forward P/E | -2.11 |
| Beta | 3.52 | Short Ratio | 12.59 | Inst. Own | 10.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 1.23 | 200-d Avg | 1.31 | 1yr Est | 5.50 |
VANI News
globenewswire.com
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr
ALAMEDA, Calif., June 26, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or
benzinga.com
Vivani Medical Receives Approval From Australian Human Research Ethics Committee Bellberry To Initia
Vivani CEO Adam Mendelsohn, Ph.D., stated, "HREC approval to initiate SLIM-1 in Australia marks
globenewswire.com
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial o
ALAMEDA, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or
benzinga.com
Lake Street Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $4
Lake Street analyst Thomas Flaten initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy r